20 results
8-K
EX-10.1
XLO
Xilio Therapeutics Inc
28 Mar 24
Entry into a Material Definitive Agreement
7:55am
-corruption laws; (b) the Company and each of its subsidiaries and controlled affiliates have conducted their businesses in compliance with applicable … anti-corruption laws and instituted at the time of the offering and will maintain policies and procedures reasonably designed to promote and achieve
S-3
EX-1.2
l3wninw72n4910
9 Nov 22
Shelf registration
4:15pm
10-K
4gsfd nrl6jz06edudn
1 Mar 22
Annual report
4:07pm
10-Q
aiu70rs4t e70
2 Dec 21
Quarterly report
4:15pm
424B4
vuv8975wy
22 Oct 21
Prospectus supplement with pricing info
4:02pm
S-1/A
EX-1.1
dlnsvwcfj6 7sc32mtc
18 Oct 21
IPO registration (amended)
6:04am
S-1/A
pjxb47r8bmfu3 4rqnj
18 Oct 21
IPO registration (amended)
6:04am
S-1
hs0f19yxab8j skj8j
1 Oct 21
IPO registration
4:49pm
DRS/A
l3z7eo53o8y
14 Sep 21
Draft registration statement (amended)
12:00am
DRS
4edodg
24 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next